Metraipolis › archive › dc_576859e375ee

Meta-analysis of secondary hematologic malignancy risks following radioactive iodine therapy for differentiated thyroid cancer — Europe PMC PMID:40552857

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40552857
DOI
10.1097/js9.0000000000002813
License (as archived)
solo-consultazione
Archived
2026-10-07T13:18:43.378Z
SHA-256 of the archived text
d9e159da39c205f4fe5b01212131621b39d5cb506201ae1185d1de763a35c770
Stable URL of this page
https://metraipolis.com/documento/dc_576859e375ee

How to cite

Meta-analysis of secondary hematologic malignancy risks following radioactive iodine therapy for differentiated thyroid cancer — Europe PMC PMID:40552857 — Europe PMC (en), https://europepmc.org/article/MED/40552857 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_576859e375ee (Metraipolis archive dc_576859e375ee, sha256 d9e159da39c205f4fe5b01212131621b39d5cb506201ae1185d1de763a35c770)
BibTeX
@misc{dc576859e375ee,
  title = {Meta-analysis of secondary hematologic malignancy risks following radioactive iodine therapy for differentiated thyroid cancer — Europe PMC PMID:40552857},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40552857},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_576859e375ee; sha256 d9e159da39c205f4fe5b01212131621b39d5cb506201ae1185d1de763a35c770},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40552857. Agents can read the archived copy with the MCP tool read_document.